Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disorders and Stroke (NINDS). https://reporter.nih.gov/project-details/11183315   The grant, valued at up to $699,933, is titled “Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain”. The project supports the discovery of anti-inflammatory molecules of the parmodulin class at Function Therapeutics, and their testing in models of...

Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...

In the Journal of Thrombosis and Haemostasis, the lab of Dr. James Luyendyk (Michigan State University) and colleagues reported the...